(4R,7R,8R,23R,39aR)-45-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-20,46-dichloro-8,23,29,31,33-pentahydroxy-7-((S)-4-methyl-2-(methylamino)pentanamido)-2,6,25,39,40-pentaoxo-1,2,3,4,5,6,7,8,24,25,26,27,37,38,39,39a-hexadecahydro-23H-24,37-(epiminomethano)-9,12:19,22-dietheno-14,17:32,36-di(metheno)benzo[n][1]oxa[6,10]diazacycloheptadecino[4,5-d][1]oxa[7,17]diazacyclotetracosine-4,27-dicarboxylic acid
Vancomycin EP Impurity E ([L-beta-Asp3]-Vancomycin) is a fully characterized chemical compound used as a reference standard of API Vancomycin. The standard offered is compliant with regulatory guidelines. Vancomycin EP Impurity E ([L-beta-Asp3]-Vancomycin) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 55598-85-1